Pharmacokinetics and Safety of NM441, a New Quinolone, in Healthy Male Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of NM441, a New Quinolone, in Healthy Male Volunteers

Published:1994-09 Issue:9 Volume:34 Page:930-937
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Nakashima M.,Uematsu T.,Kosuge K.,Okuyama Y.,Morino A.,Ozaki M.,Takebe Y.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1994.tb04007.x/fullpdf

Reference8 articles.

1. Morino A Okuyama Y Momota K Ohyabu M Pharmacokinetics of NM441, a new quinolone, in laboratory animals 1992

2. In vitro antibacterial activity of a new quinolone, NM394;Ozaki;Antimicrob Agents Chemother,1991

3. In vivo evaluation of NM441, a new thiazeto-quinoline derivative;Ozaki;Antimicrob Agents Chemother,1991

4. Influence of food on the bioavailability of drugs;Melander;Clin Pharmacokinet,1978

5. Clinical pharmacology of antimicrobial pyridonecarboxylic acids (I): Comparative study on pharmacokinetics in healthy humans and antimicrobial activity;Nakashima;Chemotherapy (Tokyo),1990

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses;Clinical Pharmacokinetics;2024-05-28

2. A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study;Clinical and Translational Science;2023-10-28

3. New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment;Drugs in R&D;2018-08-27

4. Resonance Light-Scattering Enhancement Effect of the Y(III)–PUFX–Eosin System and its Fluorescence Study;Pharmaceutical Chemistry Journal;2018-05

5. Bioanalytical method development for quantification of ulifloxacin, fenbufen and felbinac in rat plasma by solid-phase extraction (SPE) and HPLC with PDA detection;Journal of Pharmaceutical and Biomedical Analysis;2016-05